Common use of PAYMENTS BASED ON SALES OF DEVELOPED TECHNOLOGY PRODUCTS AND PRE-SELECTION PRODUCTS Clause in Contracts

PAYMENTS BASED ON SALES OF DEVELOPED TECHNOLOGY PRODUCTS AND PRE-SELECTION PRODUCTS. (a) Allergan shall pay Developed Technology Royalties to ASTI, on a country-by-country basis, equal to the sum of (i) 1% of Allergan's Net Sales in the relevant country of each Developed Technology Product plus (ii) 10% of any Sublicensing Revenues with respect to such Developed Technology Product. Only one payment under this Section 7.4 shall be payable by Allergan to ASTI with respect to Net Sales of each Developed Technology Product in any country, regardless of the number of patents covering such Developed Technology Product in such country. Subject to Section 7.5, payments with respect to sales of a Developed Technology Product in any country shall be made by Allergan until the expiration of the last to expire of the patent or patents covering such Developed Technology Product in any country.

PAYMENTS BASED ON SALES OF DEVELOPED TECHNOLOGY PRODUCTS AND PRE-SELECTION PRODUCTS. (aA) Allergan shall pay Developed Technology Royalties to ASTI, on a country-by-country basis, equal to the sum of (i) 1% of Allergan's Net Sales in the relevant country of each Developed Technology Product plus (ii) 10% of any Sublicensing Revenues with respect to such Developed Technology Product. Only one payment under this Section 7.4 shall be payable by Allergan to ASTI with respect to Net Sales of each Developed Technology Product in any country, regardless of the number of patents covering such Developed Technology Product in such country. Subject to Section 7.5, payments with respect to sales of a Developed Technology Product in any country shall be made by Allergan until the expiration of the last to expire of the patent or patents covering such Developed Technology Product in any country.